Results of Phase I Tolerability LX214 (0.2%) Voclosporin Topical Solution in Healthy Volunteers and Subjects With Dry Eye Disease
用户qgRSP4os3S6M
24天前
36
10
已关闭
DOI:
文献链接:
其他信息:
MA Lemp, R Beckman, S Weiss
… Ophthalmology & Visual …, 2010
iovs.arvojournals.org
… Systemic voclosporin exposure was assessed with pharmacokinetic measurement in … with Dry Eye Disease was seen at 2 weeks. Systemic exposure of voclosporin was minimal. …